Incyte
INCY
114.63
-1.25
-1.07%
Incyte
US · INCY
#803 by market cap
Listed 1970
114.63
-1.25
-1.07%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
3 1
■ Upgrades■ Downgrades
- 3 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: BMO Capital moved from Sell to Hold on 2026-07-29.
Analyst consensus 17 analysts
Buy
Avg price target 136.65 +19.2%
Price target rangecurrent 114.63
Low115.00
Avg136.65
High157.00
Buy 59%
Hold 41%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-19 | Leerink Partners | -- | Buy | 148.00 |
| 2026-11-17 | CCORF | -- | Buy | 152.00 |
| 2026-11-17 | H.C. Wainwright | -- | Buy | 152.00 |
| 2026-11-16 | Piper Sandler | -- | Buy | 130.00 |
| 2026-11-16 | BMO Capital | -- | Hold | 130.00 |
| 2026-11-13 | BofA Securities | -- | Buy | 143.00 |
| 2026-11-05 | CCORF | -- | Buy | 152.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 150.00 |
| 2026-11-05 | H.C. Wainwright | -- | Buy | 152.00 |
| 2026-11-02 | BofA Securities | -- | Buy | 143.00 |
| 2026-11-02 | BMO Capital | -- | Hold | 130.00 |
| 2026-11-02 | H.C. Wainwright | -- | Buy | 152.00 |
| 2026-10-30 | CCORF | -- | Buy | 152.00 |
| 2026-10-30 | UBS | -- | Hold | 127.00 |
| 2026-10-30 | Evercore | -- | Hold | 127.00 |
| 2026-10-30 | Stifel | -- | Buy | 157.00 |
| 2026-10-30 | H.C. Wainwright | -- | Buy | 152.00 |
| 2026-10-30 | Barclays | -- | Buy | 143.00 |
| 2026-10-29 | Wells Fargo | -- | Hold | 127.00 |
| 2026-10-29 | Guggenheim | -- | Buy | 152.00 |
| 2026-10-29 | Oppenheimer | -- | Buy | 144.00 |
| 2026-10-29 | RBC Capital | -- | Hold | 117.00 |
| 2026-10-28 | Barclays | -- | Buy | 139.00 |
| 2026-10-27 | CCORF | -- | Buy | 152.00 |
| 2026-10-27 | Truist Financial | -- | Hold | 115.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-29 | BMO Capital | Sell → Hold | 130.00 |
| 2026-07-28 | Oppenheimer | Hold → Buy | 120.00 |
| 2026-01-20 | Wells Fargo | Buy → Hold | 107.00 |
| 2025-11-03 | Guggenheim | Hold → Buy | 125.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | -- | ±7.84% | -0.06% (in line) |
| 2026/Q2 | 2026-07-28 | -- | ±7.10% | +9.30% (beat) |
| 2026/Q1 | 2026-04-28 | -- | ±6.28% | +2.12% (in line) |
| 2025/Q4 | 2026-02-10 | -- | ±5.60% | -8.24% (beat) |
| 2025/Q3 | 2025-10-28 | -- | ±11.05% | -1.54% (in line) |
| 2025/Q2 | 2025-07-29 | -- | ±6.40% | +10.28% (beat) |
| 2025/Q1 | 2025-04-29 | -- | ±8.74% | +1.53% (in line) |
| 2024/Q4 | 2025-02-10 | -- | ±11.46% | -7.86% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±7.46% | +12.04% (beat) |
| 2024/Q2 | 2024-07-30 | -- | ±8.18% | -1.17% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±8.55% | -0.97% (in line) |
| 2023/Q4 | 2024-02-13 | -- | ±11.43% | +2.59% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
Incyte discussion 0 comments